JENBURPH

HealthcareDrug Manufacturers - Specialty & Generic0
Jenburkt Pharmaceuticals Ltd
₹1,028.5
Previous trading day close · Data updates nightly
73/100
GoodResearch Score
Market Cap
N/A
P/E Ratio
13.82
Below avg
P/B Ratio
2.87
Reasonable
ROE
20.3%
Strong
ROCE
23.2%
Excellent
Debt / Equity
0.01
Low debt
Div. Yield
2.0%
Low yield
EV/EBITDA
9.76
Attractive
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
80/100
Growth
Revenue, EPS, profit growth
66/100
Valuation
PE, PB, EV/EBITDA vs sector
69/100
Risk
Debt levels, volatility, coverage
94/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
13.82(Below avg)
Forward P/E
N/A
P/B Ratio
2.87(Reasonable)
P/S Ratio
2.75(Good)
EV/EBITDA
9.76(Attractive)
Dividend Yield
2.0%
5Y CAGR
18.7%(High growth)
Revenue Growth
13.0%(Moderate)
Profitability
ROE
20.3%(Excellent)
ROCE
23.2%(Excellent)
ROA
17.8%(Efficient)
Net Margin
19.5%(High)
EBITDA Margin
29.7%
Financial Health
Debt to Equity
0.01(Low debt)
Current Ratio
3.00(Healthy)
Quick Ratio
2.53(Good)
Interest Coverage
101.69x(Comfortable)
Technical Indicators
Based on previous trading day close
Volume
1.1K
Shareholding Pattern
Promoter
46.6%
Moderate
FII
0.0%
DII / MF
0.1%
Share JENBURPH
Share this stock analysis with your network
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
JENBURPH Share Price - ₹1028.50 | Research Score & Analysis | StockSage Pro